Lexicon Pharmaceuticals
LXRX
LXRX
107 hedge funds and large institutions have $540M invested in Lexicon Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.47% less ownership
Funds ownership: 83.99% → 81.52% (-2.5%)
24% less capital invested
Capital invested by funds: $710M → $540M (-$170M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
107
Holding in Top 10
1
Calls
$2.83M
Puts
$1.36M
Top Buyers
| 1 | +$4.22M | |
| 2 | +$3.41M | |
| 3 | +$2.49M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.82M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$1.58M |
Top Sellers
| 1 | -$7.65M | |
| 2 | -$2.71M | |
| 3 | -$2.62M | |
| 4 |
Renaissance Technologies
New York
|
-$1.16M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$1.05M |